CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (INSULIN PUMP) THERAPY CAN BE SAFELY USED IN THE HOSPITAL IN SELECT PATIENTS
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (INSULIN PUMP) THERAPY CAN BE SAFELY USED IN THE HOSPITAL IN SELECT PATIENTS
复制标题
DOI：
10.4158/ep.15.1.24
复制
发表时间：
2009-01-01
影响因子：
4.2
通讯作者：
Cook, Curtiss B.
中科院分区：
文献类型：
--
作者：
Bailon, Rachel M.;Partlow, Brenda J.;Cook, Curtiss B.
目的：对2005年11月1日至2008年2月8日在教学医院接受胰岛素泵治疗的住院患者进行分析，了解住院患者对住院程序、血糖控制和安全性的依从性。方法：对2005年11月1日至2008年2月8日在教学医院接受胰岛素泵治疗的患者的病历和床边血糖数据进行回顾性分析。35例患者的平均年龄和病程分别为55岁和32岁。66%是女性，91%患有I型糖尿病。31例住院患者(62%)被认为是住院期间继续接受胰岛素泵治疗的对象。在31例住院患者中，80%入院时有记录的泵存在；100%有入院时的血糖值；77%有签署的患者同意文件；81%有完成预先打印的胰岛素泵订单的证据；77%接受了内分泌咨询；68%有完整的床边流程图。继续胰岛素泵治疗的患者的平均床边血糖水平与停止胰岛素泵治疗的患者相似(P=.11)，但低血糖事件在胰岛素泵使用者中的比例较低(P
Objective: To analyze data on inpatient insulin pump use and examine staff compliance with hospital procedures, glycemic control, and safety.Methods: We conducted a retrospective review of charts and bedside glucose data for patients who had been receiving outpatient insulin pump therapy and were admitted to our teaching hospital between November 1, 2005, and February 8, 2008.Results: During the study period, there were 50 hospitalizations involving 35 patients who had been receiving outpatient insulin pump therapy. The mean age and duration of diabetes of the 35 patients was 55 years and 32 years, respectively. Sixty-six percent were women, and 91% had type I diabetes. Patients in 3 1 of the hospitalizations (62%) were deemed candidates for continued insulin pump therapy during their stay. Of the 31 hospitalizations, 80% had the presence of the pump documented at admission; 100% had an admission glucose value; 77% had documentation of signed patient consent; 81% had evidence of completed preprinted insulin pump orders; 77% received an endocrine consultation; and 68% had a completed bedside flow sheet. Patients continuing insulin pump therapy had mean bedside glucose levels similar to those whose pump therapy was discontinued (P = .11), however, the proportion of hypoglycemic events was lower among insulin pump users (P